Evoke Pharma (EVOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,538 | -6,866 | -4,896 | -2,606 | -13,155 |
| Accounts receivable | -272 | -199 | -175 | -105 | N/A |
| Other Working Capital | -5,619 | -4,810 | -423 | -804 | 4,896 |
| Other Operating Activity | 2,076 | 1,519 | 1,031 | 561 | 1,629 |
| Operating Cash Flow | $-12,353 | $-10,356 | $-4,464 | $-2,953 | $-6,630 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 5,104 |
| Common Stock Issued | 14,740 | 14,740 | 14,421 | 13,070 | 3,931 |
| Other Financing Activity | -1,311 | -1,311 | -1,305 | 0 | 0 |
| Financing Cash Flow | $13,429 | $13,429 | $13,116 | $13,070 | $9,035 |
| Beginning Cash Position | 8,069 | 8,069 | 8,069 | 8,069 | 5,664 |
| End Cash Position | 9,145 | 11,142 | 16,721 | 18,186 | 8,069 |
| Net Cash Flow | $1,076 | $3,073 | $8,652 | $10,117 | $2,405 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,353 | -10,356 | -4,464 | -2,953 | -6,630 |
| Free Cash Flow | -12,353 | -10,356 | -4,464 | -2,953 | -6,630 |